Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study. (March 2018)

• Record Type: Journal Article
• Authors: Pham, Thu Hang; Peter, Jonathan; Mello, Fernanda C.Q.; Parraga, Tommy; Lan, Nguyen Thi Ngoc; Nabeta, Pamela; Valli, Eloise; Caceres, Tatiana; Dheda, Keertan; Dorman, Susan E.; Hillemann, Doris; Gray, Christen M.; Perkins, Mark D.
• Is Part Of: International journal of infectious diseases. Volume 68(2018)
• Page Start: 44
• Page End: 49
• Publication Date: 2018-03
• Subjects: Mycobacterium tuberculosis -- Polymerase chain reaction -- Clinical trials; Communicable diseases -- Periodicals; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; Electronic journals; 616.9
• DOI: 10.1016/j.ijid.2018.01.005
• Languages: English
• ISSNs: 1201-9712

Abstract

Highlights: TB-LAMP sensitivity was 75.6% in samples from culture-confirmed TB cases. TB-LAMP detected 97.9% of smear-positive TB and 46.6% of smear-negative TB. TB-LAMP specificity was 98.7% in samples from culture-negative participants. The performance of TB-LAMP was similar to that of Xpert MTB/RIF in this study. Abstract: Objective: To evaluate the diagnostic performance of TB-LAMP, a manual molecular tuberculosis (TB) detection method, and provide comparison to the Xpert MTB/RIF assay. Methods: In a large multicentre study, two sputum samples were collected from participants with TB symptoms in reference laboratories in Peru, South Africa, Brazil, and Vietnam. Each sample was tested with TB-LAMP. The reference standard consisted of four direct smears, four cultures, and clinical and radiological findings. Individuals negative on conventional tests were followed up after 8 weeks. The Xpert MTB/RIF assay was performed on fresh or frozen samples as a molecular test comparison. Results: A total of 1036 adults with suspected TB were enrolled. Among 375 culture-confirmed TB cases with 750 sputum samples, TB-LAMP detected 75.6% (95% confidence interval (CI) 71.8–79.4%), including 97.9% (95% CI 96.4–99.4%) of smear-positive TB samples and 46.6% (95% CI 40.6–52.7%) of smear-negative TB samples. Specificity in 477 culture-negative participants not treated for TB (954 sputum samples) was 98.7% (95% CI 97.9–99.6%). TB-LAMP test results were indeterminate in 0.3% of cases. Conclusions: TB-LAMP detects nearly all smear-positive and half of smear-negative TB cases and has a high specificity when performed in reference laboratories. Performance was similar to the Xpert MTB/RIF assay.